Rebound cerebrospinal fluid pleocytosis with elevated cytokine levels during recombinant human granulocyte colony-stimulating factor therapy for purulent meningitis.
Isoyama
K
K
Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan. isoyamak@med.showa-u.ac.jp
Imai
M
M
Yamada
K
K
D002097:C-Reactive Protein / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000737:chemistry* / Q000187:drug effects* / Q000276:immunology; D016207:Cytokines / Q000032:analysis*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000032:analysis / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced* / Q000276:immunology; D016920:Meningitis, Bacterial / Q000097:blood / Q000134:cerebrospinal fluid* / Q000276:immunology / Q000628:therapy*; D009504:Neutrophils; D011994:Recombinant Proteins; D012008:Recurrence; D013492:Suppuration
D016207:Cytokines; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D002097:C-Reactive Protein